Zimmer Biomet Holdings Inc (NYSE:ZBH)
$ 121.31 -0.13 (-0.11%) Market Cap: 24.96 Bil Enterprise Value: 30.52 Bil PE Ratio: 26.26 PB Ratio: 1.98 GF Score: 83/100

Zimmer Biomet Holdings Inc at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 03:10PM GMT
Release Date Price: $134.38 (+1.05%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

All right. Let's take our seats, go ahead and get started. My name is David Lewis, medical device analyst at Morgan Stanley. Thank you all for joining us here as we progress through the morning of day 2 of the Morgan Stanley health care conference. We've got several members of management from Zimmer Biomet: Bryan Hanson, CEO; Suky Upadhyay, the CFO -- recently appointed CFO; and obviously, Cole Lannum, you all know and love.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

So I think, Bryan, we'd start just initially just kind of giving kind of a recap maybe, I thought. What's transpired here since you sort of became CEO? I think what -- where have you been in terms of some the progress you've made? And sort of what is -- what are the big points that are still outstanding?

Bryan C. Hanson
Zimmer Biomet Holdings, Inc. - President, CEO & Director

Yes. So right out of the gate, we've had pretty good consistency in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot